Mary Woolley Weekly Advocacy Messages
During his State of the Union address, when President Trump laid out the goal of ending the HIV/AIDS epidemic in the U.S., it brought to mind the critical role research has played in making eradication even plausible.
As you know, there has been a cease fire in the shutdown and people are back to work, at least for now.
The impact of the partial government shutdown – now entering its second month – continues to reverberate across the U.S., causing individual suffering and squandering progress at the expense of us all.
The partial government shutdown continues, now at day 27. There are too many furloughed workers struggling to make ends meet, our nation’s parks and monuments are being ruined, research support by NSF has been put on hold, and drug approvals have slowed at FDA.
In welcome news, last night the (departing) 115th Senate voted to confirm Dr. Kelvin Droegemeier as Director of the White House Office of Science and Technology Policy (OSTP).
The government is now in its sixth day of a partial shutdown that has left agencies including the Food and Drug Administration (FDA) and National Science Foundation (NSF) without the necessary resources to conduct their critical, multi-faceted work.
Today, our nation and world lost a research leader whose vision, commitment and compassion have catalyzed progress against a host of insidious health threats. Dr. Stephen Katz, the director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, died suddenly and unexpectedly this morning.
Votes and other Congressional activities were suspended this week to mourn the passing of our nation’s 41st President, George H.W. Bush.
This week has been rife with chilling public health news. You may have seen the widely-covered announcement that life expectancy in the United States has once again dropped, driven for a third year in a row by opioid (including fentanyl) abuse, a surge in suicide, especially in rural areas, and a spike in flu deaths.
Earlier this week I had the privilege of meeting with and addressing faculty and students at Weill Cornell Graduate School of Medical Sciences and at Rutgers University. During both trips, it was truly energizing...